Methyl iodide → 4-Methoxy-2-(4-methyl-5-oxo-2,5-dihydrofuran-3-yl)-2,8-diazaspiro[4.5]decan-1-one

HRID 1501800ノート

反応式

HRID 1501800 の反応式
[CH3:1][O:2][CH:3]1[C:7]2([CH2:12][CH2:11][N:10](C(OC(C)(C)C)=O)[CH2:9][CH2:8]2)[C:6](=[O:20])[N:5]([C:21]2[CH2:22][O:23][C:24](=[O:27])[C:25]=2[CH3:26])[CH2:4]1.OC1C2(CCN(C(OC(C)(C)C)=O)CC2)C(=O)N(C2COC(=O)C=2C)C1.IC.[Al]>C(#N)C.[Ag]=O>[CH3:1][O:2][CH:3]1[C:7]2([CH2:12][CH2:11][NH:10][CH2:9][CH2:8]2)[C:6](=[O:20])[N:5]([C:21]2[CH2:22][O:23][C:24](=[O:27])[C:25]=2[CH3:26])[CH2:4]1

参加物

7

反応条件

温度
58 °C

実験手順

tert-Butyl 4-methoxy-2-(4-methyl-5-oxo-2,5-dihydrofuran-3-yl)-1-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate (Enantiomer A and Enantiomer B): To a solution of tert-butyl 4-hydroxy-2-(4-methyl-5-oxo-2,5-dihydrofuran-3-yl)-1-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate (100 mg, 0.273 mmol) in acetonitrile (1 mL) was added iodomethane (171 μL, 2.73 mmol) and silver oxide (69.6 mg, 0.300 mmol). The vial was sealed, wrapped with aluminum foil, and stirred at 58° C. for 15 h. The reaction mixture was filtered through CELITE®, concentrated to give the crude product, which was purified by column chromatography (0-10% MeOH/DCM) to afford the title compound as a mixture of enantiomers. LC/MS: [(M+1)]+=381. The racemic mixture was separated by SFC-HPLC, using the following conditions: chiralcel AD-H, 2×25 cm, 15% MeOH, 60 mL/min to afford faster eluting Enantiomer A: LC/MS: [(M+1)]+=381; and slower eluting Enantiomer B: LC/MS: [(M+1)]+=381

後処理

  1. customThe vial was sealed
  2. filtrationThe reaction mixture was filtered through CELITE®
  3. concentrationconcentrated
  4. customto give the crude product, which
  5. customwas purified by column chromatography (0-10% MeOH/DCM)

出典と根拠

ORDレコード
ord-6dd607733de34e7b82d2dab3e8b7b2f7
出典データセット
uspto-grants-2015_12
特許番号
US09206198B2

反応ノート

読み込み中…